We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Newly Upgraded Software Suite Expands Microscopy Applications

By LabMedica International staff writers
Posted on 06 Oct 2014
A newly upgraded software suite improves image acquisition, processing, and analysis for most applications including widefield, confocal, and super-resolution microscopy.

Leica Microsystems (Wetzlar, Germany) has launched the easy-to-use Leica Application Suite X (LAS X) imaging software for biotech and life sciences research laboratories. More...
LAS X is the successor to the popular LAS AF software package.

LAS X begins with the LAS X Core unit that features microscope control, full image viewer capability, diverse processing and quantification tools, movie export, the ability to recall imaging parameters and much more. Several application packages are available that enhance the versatility of the core unit. These include modules for specific tasks such as high content screening, FRET (Fluorescence Resonance Energy Transfer), FRAP (Fluorescence Recovery after Photobleaching), multidimensional analysis, and colocalization measurements.

For live cell applications, hardware-based Adaptive Focus Control (AFC) and software-based autofocus are integrated in LAS X. Experimental conditions such as temperature, carbon dioxide and oxygen levels are documented and controlled with the Environmental Control module. For long-term time-lapse and screening experiments, the software-controlled microdispenser compensates for evaporation.

LAS X enables easy multichannel analysis of even complicated fluorescent experiments. A separate analysis channel can be created for each fluorescent marker and assigned an individual workflow. Analysis of all aspects of the sample can then be run at the same time. Combined analyses from separate channels generate specific object data. For example, one analysis channel can count healthy cells on a stained color image while a second analysis channel counts abnormal cells.

Markus Schechter, product manager at Leica Microsystems, said, "In developing the new imaging software platform LAS X, we have focused on the user-friendliness of the software. We have taken common workflows most users know and follow into account and translated them into software and this way continued the workflow-based approach of the predecessor LAS AF."

Related Links:
Leica Microsystems



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.